Table 2 A commonly used risk group stratification scheme
| Risk group | Clinical stage | PSA | Gleason score | ||
|---|---|---|---|---|---|
| Low (0) | ≤ T2b | AND | ≤ 10 | AND | ≤ 6 |
| Intermediate (1) | > T2b | OR | > 10 | OR | > 6 |
| High (≥ 2) | > T2b | AND/OR | > 10 | AND/OR | > 6 |
| Risk group | Clinical stage | PSA | Gleason score | ||
|---|---|---|---|---|---|
| Low (0) | ≤ T2b | AND | ≤ 10 | AND | ≤ 6 |
| Intermediate (1) | > T2b | OR | > 10 | OR | > 6 |
| High (≥ 2) | > T2b | AND/OR | > 10 | AND/OR | > 6 |